LabConnect, a global provider of central laboratory and support services for the biopharmaceutical industry, finalized plans to add 20,000 sq.-ft. at its Johnson City facility. In response to demand for its services for cell and gene therapies, immuno-oncology, and other advanced therapeutics, the expansion triples kit building capacity along with other planned operational improvements.   “LabConnect’s expansion is a direct result of tremendous client response to our differentiated...